Inventor · disambiguated record
Edward A. Kesicki
Also filed as: KESICKI EDWARD · KESICKI EDWARD A
55 granted patents·18 pending applications·1,992 citations·filing 1988–2024
99Inventor score
Top patents by PatentIndex Score
73 records- 0198US8980901B25-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 17, 2015·39 cites·21 claims
- 0298USRE44599EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 12, 2013·44 cites·6 claims
- 0398US7932260B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2005·Granted Apr 26, 2011·221 cites·2 claims
- 0498US6949535B2Inhibitors of human phosphatidyl-inositol 3-kinase deltaICOS CORP·Filed 2003·Granted Sep 27, 2005·172 cites·15 claims
- 0598US6667300B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Dec 23, 2003·174 cites·12 claims
- 0698US6518277B1Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Feb 11, 2003·272 cites·13 claims
- 0797US8779131B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Jul 15, 2014·30 cites·10 claims
- 0897US8637533B2Inhibitors of human phosphatidylinositol 3-kinase deltaSADHU CHANCHAL·Filed 2012·Granted Jan 28, 2014·48 cites·18 claims
- 0997US8623881B2Inhibitors of human phosphatidylinositol 3-kinase deltaSADHU CHANCHAL·Filed 2009·Granted Jan 7, 2014·41 cites·7 claims
- 1097US8586597B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 19, 2013·36 cites·6 claims
- 1197US8492389B2Inhibitors of human phosphatidylinositol 3-kinase deltaSADHU CHANCHAL·Filed 2009·Granted Jul 23, 2013·47 cites·11 claims
- 1297US8207153B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2010·Granted Jun 26, 2012·51 cites·6 claims
- 1396US8993583B25-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 31, 2015·22 cites·13 claims
- 1496USRE44638EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2005·Granted Dec 10, 2013·46 cites·2 claims
- 1596US8138195B2Inhibitors of human phosphatidylinositol 3-kinase deltaSADHU CHANCHAL·Filed 2005·Granted Mar 20, 2012·64 cites·72 claims
- 1696US6800620B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS·Filed 2003·Granted Oct 5, 2004·225 cites·43 claims
- 1795US10010550B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2017·Granted Jul 3, 2018·11 cites·2 claims
- 1895US9487772B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Nov 8, 2016·19 cites·1 claims
- 1995US9149477B25-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2014·Granted Oct 6, 2015·17 cites·12 claims
- 2095US8653077B2Inhibitors of human phosphatidylinositol 3-kinase deltaSADHU CHANCHAL·Filed 2011·Granted Feb 18, 2014·39 cites·30 claims
- 2195US7179912B2Materials and methods to potentiate cancer treatmentLUITPOLD PHARM INC·Filed 2001·Granted Feb 20, 2007·79 cites·7 claims
- 2294US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 2392US10398695B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2018·Granted Sep 3, 2019·5 cites·2 claims
- 2491US10695349B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2019·Granted Jun 30, 2020·2 cites·2 claims
- 2591US10336756B2(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2015·Granted Jul 2, 2019·5 cites·2 claims
- 2690US11873295B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 16, 2024·3 cites·125 claims
- 2789US7067506B2Compounds useful for inhibiting Chk1ICOS CORP·Filed 2002·Granted Jun 27, 2006·31 cites·25 claims
- 2889US6458787B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Oct 1, 2002·24 cites·22 claims
- 2988US7608618B2Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1ICOS CORP·Filed 2005·Granted Oct 27, 2009·9 cites·2 claims
- 3088US6258833B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1999·Granted Jul 10, 2001·55 cites·37 claims
- 3187US6075126APhenyldiboronic acid reagents and complexesPROLINX INC·Filed 1998·Granted Jun 13, 2000·26 cites·15 claims
- 3285US8338477B2Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefitsDUNCAN IAIN W·Filed 2009·Granted Dec 25, 2012·16 cites·19 claims
- 3384US6716871B2Cyclic AMP-specific phosphodie sterase inhibitorsICOS CORP·Filed 2002·Granted Apr 6, 2004·14 cites·5 claims
- 3481US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 3580US6124471APhenyldiboronic acid reagents and complexesPROLINX INC·Filed 1999·Granted Sep 26, 2000·16 cites·4 claims
- 3679US8093244B2Heteroaryl urea derivatives useful for inhibiting CHK1DIAZ FRANK·Filed 2006·Granted Jan 10, 2012·9 cites·3 claims
- 3778US11667651B2Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Jun 6, 2023·1 cites·11 claims
- 3878US10906907B2Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereofICOS CORP·Filed 2019·Granted Feb 2, 2021·0 cites·9 claims
- 3977US2021332047A1Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2020·Application pending·0 cites
- 4070US12006332B2Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2022·Granted Jun 11, 2024·0 cites·15 claims
- 4170US2024158415A1Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 4269US8404681B2Xanthones, thioxanthones and acridinones as DNA-PK inhibitorsHALBROOK JAMES W·Filed 2004·Granted Mar 26, 2013·7 cites·18 claims
- 4369US2024051948A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 4468US9951046B2TRPA1 modulatorsALGOMEDIX INC·Filed 2016·Granted Apr 24, 2018·1 cites·55 claims
- 4568US2024383878A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2024·Application pending·0 cites
- 4666US6998416B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2004·Granted Feb 14, 2006·1 cites·2 claims
- 4766US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 4865US2017049772A1Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2016·Application pending·0 cites
- 4964US6462179B1Phenyldiboronic acid reagents and complexesPROLINX INC·Filed 2000·Granted Oct 8, 2002·15 cites·5 claims
- 5064US2010105683A1Compounds useful for inhibiting chk1KEEGAN KATHLEEN S·Filed 2009·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Edward A. Kesicki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →